The efficacy and safety of Jingfang Granules in treating air-conditioning diseases
- Conditions
- The Disease of Air Conditioning
- Registration Number
- ITMCTR2000003664
- Lead Sponsor
- Zhangjiagang Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
The subject must meet all of the following criteria at the same time:
(1) Male or female between 18 and 70 years old;
(2) The experience of being exposed to an air-conditioned environment or frequently entering and leaving air-conditioned rooms on hot days (June to October) and at least 3 days before the onset;
(3) Meet the diagnostic criteria of Western medicine for the common cold (edited by Chen Haozhu. Practical Internal Medicine. 10th edition. People's Medical Publishing House);
(4) Comply with the diagnostic criteria of TCM syndromes for wind-cold cold [Guidelines for TCM Diagnosis and Treatment of Common Colds (2015 Edition)];
(5) Within 48 hours of onset;
(6) Those who have not taken Jingfang Granules, Xinkangtai Ke (blue), Tylenol cold tablets, Xinkang Taike (red), Day and Night Baifuzhu (night tablets), etc. within 2 weeks before enrollment;
(7) Subjects voluntarily joined the study and signed an informed consent form.
Exclude subjects who meet any of the following criteria:
(1) Diseases accompanied by pharyngeal conjunctivitis, acute exacerbation of chronic bronchitis, purulent tonsillitis, and infectious upper respiratory tract infection;
(2) People with uncontrolled cardiovascular and cerebrovascular diseases, diabetes, hypertension, thyroid disease, asthma, glaucoma, emphysema, chronic lung diseases, breathing difficulties or prostatic hypertrophy;
(3) Patients with pneumonia confirmed by chest imaging;
(4) Those who have used drugs to treat the disease after the onset of illness;
(5) Those who are currently taking nourishing proprietary Chinese medicines or monoamine oxidase inhibitors;
(6) Aspartate aminotransferase (AST) or alanine aminotransferase (ALT)> 3 times the upper limit of normal value or active liver disease;
(7) Serum creatinine> 2 times the upper limit of normal or undergoing renal dialysis treatment;
(8) Axillary temperature >= 40 degrees C, total number of white blood cells>10x109/L or neutrophil classification>80%;
(9) Those who are allergic to the drugs used in this research;
(10) Mental and neurological disorders, who cannot express their wishes correctly;
(11) Pregnant women, lactating women and women of childbearing age who have not taken contraceptive measures;
(12) Those who are currently participating in clinical trials of other drugs or medical devices;
(13) The investigator believes that it is not suitable for inclusion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recovery rate on the 3rd day of treatment;
- Secondary Outcome Measures
Name Time Method